SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-266727
Filing Date
2021-09-07
Accepted
2021-09-07 17:04:37
Documents
14
Period of Report
2021-08-31
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d222720d8k.htm   iXBRL 8-K 34423
2 EX-5.1 d222720dex51.htm EX-5.1 11568
6 GRAPHIC g222720g57s44.jpg GRAPHIC 9397
  Complete submission text file 0001193125-21-266727.txt   188194

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrs-20210831.xsd EX-101.SCH 2873
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrs-20210831_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrs-20210831_pre.xml EX-101.PRE 11395
7 EXTRACTED XBRL INSTANCE DOCUMENT d222720d8k_htm.xml XML 3447
Mailing Address 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608
Business Address 5885 HOLLIS STREET, SUITE 100 EMERYVILLE CA 94608 510-450-0761
AMYRIS, INC. (Filer) CIK: 0001365916 (see all company filings)

IRS No.: 550856151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34885 | Film No.: 211239935
SIC: 2860 Industrial Organic Chemicals
Office of Life Sciences